<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38137114</PMID><DateRevised><Year>2024</Year><Month>03</Month><Day>07</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2076-3425</ISSN><JournalIssue CitedMedium="Print"><Volume>13</Volume><Issue>12</Issue><PubDate><Year>2023</Year><Month>Dec</Month><Day>01</Day></PubDate></JournalIssue><Title>Brain sciences</Title><ISOAbbreviation>Brain Sci</ISOAbbreviation></Journal><ArticleTitle>Cortical GABA Levels Are Reduced in Post-Acute COVID-19 Syndrome.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1666</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/brainsci13121666</ELocationID><Abstract><AbstractText>After recovering from the acute COVID-19 illness, a substantial proportion of people continue experiencing post-acute sequelae of COVID-19 (PASC), also termed "long COVID". Their quality of life is adversely impacted by persistent cognitive dysfunction and affective distress, but the underlying neural mechanisms are poorly understood. The present study recruited a group of mostly young, previously healthy adults (24.4 &#xb1; 5.2 years of age) who experienced PASC for almost 6 months following a mild acute COVID-19 illness. Confirming prior evidence, they reported noticeable memory and attention deficits, brain fog, depression/anxiety, fatigue, and other symptoms potentially suggestive of excitation/inhibition imbalance. Proton magnetic resonance spectroscopy (<sup>1</sup>H-MRS) was used to examine the neurochemical aspects of cell signaling with an emphasis on GABA levels in the occipital cortex. The PASC participants were compared to a control (CNT) group matched in demographics, intelligence, and an array of other variables. Controlling for tissue composition, biological sex, and alcohol intake, the PASC group had lower GABA+/water than CNT, which correlated with depression and poor sleep quality. The mediation analysis revealed that the impact of PASC on depression was partly mediated by lower GABA+/water, indicative of cortical hyperexcitability as an underlying mechanism. In addition, N-acetylaspartate (NAA) tended to be lower in the PASC group, possibly suggesting compromised neuronal integrity. Persistent neuroinflammation may contribute to the pathogenesis of PASC-related neurocognitive dysfunction.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Marinkovic</LastName><ForeName>Ksenija</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0003-1658-4496</Identifier><AffiliationInfo><Affiliation>Spatio-Temporal Brain Imaging Lab, Department of Psychology, San Diego State University, San Diego, CA 92182, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Radiology, University of California, San Diego, CA 92093, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>White</LastName><ForeName>David R</ForeName><Initials>DR</Initials><AffiliationInfo><Affiliation>Spatio-Temporal Brain Imaging Lab, Department of Psychology, San Diego State University, San Diego, CA 92182, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alderson Myers</LastName><ForeName>Austin</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-5537-9762</Identifier><AffiliationInfo><Affiliation>Spatio-Temporal Brain Imaging Lab, Department of Psychology, San Diego State University, San Diego, CA 92182, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Psychiatry, University of California, San Diego, CA 92093, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Parker</LastName><ForeName>Katie S</ForeName><Initials>KS</Initials><AffiliationInfo><Affiliation>Spatio-Temporal Brain Imaging Lab, Department of Psychology, San Diego State University, San Diego, CA 92182, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arienzo</LastName><ForeName>Donatello</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Spatio-Temporal Brain Imaging Lab, Department of Psychology, San Diego State University, San Diego, CA 92182, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Radiology, University of California, San Diego, CA 92093, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mason</LastName><ForeName>Graeme F</ForeName><Initials>GF</Initials><AffiliationInfo><Affiliation>Department of Radiology and Biomedical Imaging, Psychiatry, and Biomedical Engineering, Yale University, New Haven, CT 06520, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R21 AA027371</GrantID><Acronym>AA</Acronym><Agency>NIAAA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001863</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>AA027371</GrantID><Acronym>NH</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>12</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Brain Sci</MedlineTA><NlmUniqueID>101598646</NlmUniqueID><ISSNLinking>2076-3425</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">1H-MRS</Keyword><Keyword MajorTopicYN="N">GABA</Keyword><Keyword MajorTopicYN="N">NAA</Keyword><Keyword MajorTopicYN="N">anxiety</Keyword><Keyword MajorTopicYN="N">cognitive deficits</Keyword><Keyword MajorTopicYN="N">depression</Keyword><Keyword MajorTopicYN="N">excitation/inhibition balance</Keyword><Keyword MajorTopicYN="N">insomnia</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">magnetic resonance spectroscopy</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>11</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>11</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>11</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>12</Month><Day>23</Day><Hour>12</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>12</Month><Day>23</Day><Hour>12</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>12</Month><Day>23</Day><Hour>1</Hour><Minute>8</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>12</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38137114</ArticleId><ArticleId IdType="pmc">PMC10741691</ArticleId><ArticleId IdType="doi">10.3390/brainsci13121666</ArticleId><ArticleId IdType="pii">brainsci13121666</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Cutler D.M., Summers L.H. The COVID-19 Pandemic and the $16 Trillion Virus. JAMA. 2020;324:1495&#x2013;1496. doi: 10.1001/jama.2020.19759.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.19759</ArticleId><ArticleId IdType="pmc">PMC7604733</ArticleId><ArticleId IdType="pubmed">33044484</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith M.P. Estimating total morbidity burden of COVID-19: Relative importance of death and disability. J. Clin. Epidemiol. 2022;142:54&#x2013;59. doi: 10.1016/j.jclinepi.2021.10.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2021.10.018</ArticleId><ArticleId IdType="pmc">PMC8547965</ArticleId><ArticleId IdType="pubmed">34715312</ArticleId></ArticleIdList></Reference><Reference><Citation>CDC  Long COVID or Post-COVID Conditions.  [(accessed on 3 August 2023)]; Available online:  https://www.cdc.gov/coronavirus/2019-ncov/long-term-effects/index.html.</Citation></Reference><Reference><Citation>DHHS . National Research Action Plan on Long COVID. Office of the Assistant Secretary for Health; Washington, DC, USA: 2022.</Citation></Reference><Reference><Citation>Zadeh F.H., Wilson D.R., Agrawal D.K. Long COVID: Complications, Underlying Mechanisms, and Treatment Strategies. Arch. Microbiol. Immunol. 2023;7:36&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10310313</ArticleId><ArticleId IdType="pubmed">37388279</ArticleId></ArticleIdList></Reference><Reference><Citation>Soriano J.B., Murthy S., Marshall J.C., Relan P., Diaz J.V. A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect. Dis. 2022;22:e102&#x2013;e107. doi: 10.1016/S1473-3099(21)00703-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00703-9</ArticleId><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Kubota T., Kuroda N., Sone D. Neuropsychiatric aspects of long COVID: A comprehensive review. Psychiatry Clin. Neurosci. 2023;77:84&#x2013;93. doi: 10.1111/pcn.13508.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/pcn.13508</ArticleId><ArticleId IdType="pmc">PMC10108156</ArticleId><ArticleId IdType="pubmed">36385449</ArticleId></ArticleIdList></Reference><Reference><Citation>Groff D., Sun A., Ssentongo A.E., Ba D.M., Parsons N., Poudel G.R., Lekoubou A., Oh J.S., Ericson J.E., Ssentongo P. Short-term and long-term rates of postacute sequelae of SARS-CoV-2 infection: A systematic review. JAMA Netw. Open. 2021;4:e2128568. doi: 10.1001/jamanetworkopen.2021.28568.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.28568</ArticleId><ArticleId IdType="pmc">PMC8515212</ArticleId><ArticleId IdType="pubmed">34643720</ArticleId></ArticleIdList></Reference><Reference><Citation>Thaweethai T., Jolley S.E., Karlson E.W., Levitan E.B., Levy B., McComsey G.A., McCorkell L., Nadkarni G.N., Parthasarathy S., Singh U., et al. Development of a Definition of Postacute Sequelae of SARS-CoV-2 Infection. JAMA. 2023;329:1934&#x2013;1946. doi: 10.1001/jama.2023.8823.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2023.8823</ArticleId><ArticleId IdType="pmc">PMC10214179</ArticleId><ArticleId IdType="pubmed">37278994</ArticleId></ArticleIdList></Reference><Reference><Citation>Henneghan A.M., Lewis K.A., Gill E., Kesler S.R. Cognitive impairment in non-critical, mild-to-moderate COVID-19 survivors. Front. Psychol. 2022;13:770459. doi: 10.3389/fpsyg.2022.770459.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpsyg.2022.770459</ArticleId><ArticleId IdType="pmc">PMC8891805</ArticleId><ArticleId IdType="pubmed">35250714</ArticleId></ArticleIdList></Reference><Reference><Citation>Schild A.-K., Goereci Y., Scharfenberg D., Klein K., L&#xfc;lling J., Meiberth D., Schweitzer F., St&#xfc;rmer S., Zeyen P., Sahin D. Multidomain cognitive impairment in non-hospitalized patients with the post-COVID-19 syndrome: Results from a prospective monocentric cohort. J. Neurol. 2023;270:1215&#x2013;1223. doi: 10.1007/s00415-022-11444-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-022-11444-w</ArticleId><ArticleId IdType="pmc">PMC9686246</ArticleId><ArticleId IdType="pubmed">36422669</ArticleId></ArticleIdList></Reference><Reference><Citation>Munipalli B., Seim L., Dawson N.L., Knight D., Dabrh A.M.A. Post-acute sequelae of COVID-19 (PASC): A meta-narrative review of pathophysiology, prevalence, and management. SN Compr. Clin. Med. 2022;4:90. doi: 10.1007/s42399-022-01167-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s42399-022-01167-4</ArticleId><ArticleId IdType="pmc">PMC8977184</ArticleId><ArticleId IdType="pubmed">35402784</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowe B., Xie Y., Al-Aly Z. Postacute sequelae of COVID-19 at 2 years. Nat. Med. 2023;29:2347&#x2013;2357. doi: 10.1038/s41591-023-02521-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-023-02521-2</ArticleId><ArticleId IdType="pmc">PMC10504070</ArticleId><ArticleId IdType="pubmed">37605079</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A., Sehgal K., Gupta A., Madhavan M.V., McGroder C., Stevens J.S., Cook J.R., Nordvig A.S., Shalev D., Sehrawat T.S., et al. Post-acute COVID-19 syndrome. Nat. Med. 2021;27:601&#x2013;615. doi: 10.1038/s41591-021-01283-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis H.E., Assaf G.S., McCorkell L., Wei H., Low R.J., Re&#x2019;em Y., Redfield S., Austin J.P., Akrami A. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. 2021;38:101019. doi: 10.1016/j.eclinm.2021.101019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101019</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Graham E.L., Clark J.R., Orban Z.S., Lim P.H., Szymanski A.L., Taylor C., DiBiase R.M., Jia D.T., Balabanov R., Ho S.U., et al. Persistent neurologic symptoms and cognitive dysfunction in non-hospitalized COVID-19 &#x201c;long haulers&#x201d;. Ann. Clin. Transl. Neurol. 2021;8:1073&#x2013;1085. doi: 10.1002/acn3.51350.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.51350</ArticleId><ArticleId IdType="pmc">PMC8108421</ArticleId><ArticleId IdType="pubmed">33755344</ArticleId></ArticleIdList></Reference><Reference><Citation>Kondratiuk A.L., Pillay T.D., Kon O.M., Lalvani A. A conceptual framework to accelerate the clinical impact of evolving research into long COVID. Lancet Infect. Dis. 2021;21:756&#x2013;757. doi: 10.1016/S1473-3099(21)00136-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00136-5</ArticleId><ArticleId IdType="pmc">PMC8062085</ArticleId><ArticleId IdType="pubmed">33894903</ArticleId></ArticleIdList></Reference><Reference><Citation>Komaroff A.L., Bateman L. Will COVID-19 Lead to Myalgic Encephalomyelitis/Chronic Fatigue Syndrome? Front. Med. 2020;7:606824. doi: 10.3389/fmed.2020.606824.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2020.606824</ArticleId><ArticleId IdType="pmc">PMC7848220</ArticleId><ArticleId IdType="pubmed">33537329</ArticleId></ArticleIdList></Reference><Reference><Citation>Bougakov D., Podell K., Goldberg E. Multiple Neuroinvasive Pathways in COVID-19. Mol. Neurobiol. 2021;58:564&#x2013;575. doi: 10.1007/s12035-020-02152-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-020-02152-5</ArticleId><ArticleId IdType="pmc">PMC7523266</ArticleId><ArticleId IdType="pubmed">32990925</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan R., Zhang Y., Li Y., Xia L., Guo Y., Zhou Q. Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2. Science. 2020;367:1444&#x2013;1448. doi: 10.1126/science.abb2762.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abb2762</ArticleId><ArticleId IdType="pmc">PMC7164635</ArticleId><ArticleId IdType="pubmed">32132184</ArticleId></ArticleIdList></Reference><Reference><Citation>Baig A.M., Khaleeq A., Ali U., Syeda H. Evidence of the COVID-19 Virus Targeting the CNS: Tissue Distribution, Host-Virus Interaction, and Proposed Neurotropic Mechanisms. ACS Chem. Neurosci. 2020;11:995&#x2013;998. doi: 10.1021/acschemneuro.0c00122.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acschemneuro.0c00122</ArticleId><ArticleId IdType="pubmed">32167747</ArticleId></ArticleIdList></Reference><Reference><Citation>Iadecola C., Anrather J., Kamel H. Effects of COVID-19 on the Nervous System. Cell. 2020;183:16&#x2013;27.e11. doi: 10.1016/j.cell.2020.08.028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.08.028</ArticleId><ArticleId IdType="pmc">PMC7437501</ArticleId><ArticleId IdType="pubmed">32882182</ArticleId></ArticleIdList></Reference><Reference><Citation>Haroon E., Miller A.H., Sanacora G. Inflammation, Glutamate, and Glia: A Trio of Trouble in Mood Disorders. Neuropsychopharmacology. 2017;42:193&#x2013;215. doi: 10.1038/npp.2016.199.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/npp.2016.199</ArticleId><ArticleId IdType="pmc">PMC5143501</ArticleId><ArticleId IdType="pubmed">27629368</ArticleId></ArticleIdList></Reference><Reference><Citation>Maggio N., Shavit-Stein E., Dori A., Blatt I., Chapman J. Prolonged systemic inflammation persistently modifies synaptic plasticity in the hippocampus: Modulation by the stress hormones. Front. Mol. Neurosci. 2013;6:46. doi: 10.3389/fnmol.2013.00046.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2013.00046</ArticleId><ArticleId IdType="pmc">PMC3850065</ArticleId><ArticleId IdType="pubmed">24363642</ArticleId></ArticleIdList></Reference><Reference><Citation>Manganotti P., Michelutti M., Furlanis G., Deodato M., Stella A.B. Deficient GABABergic and glutamatergic excitability in the motor cortex of patients with long-COVID and cognitive impairment. Clin. Neurophysiol. 2023;151:83&#x2013;91. doi: 10.1016/j.clinph.2023.04.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinph.2023.04.010</ArticleId><ArticleId IdType="pmc">PMC10170904</ArticleId><ArticleId IdType="pubmed">37210757</ArticleId></ArticleIdList></Reference><Reference><Citation>Paudel Y.N., Shaikh M.F., Shah S., Kumari Y., Othman I. Role of inflammation in epilepsy and neurobehavioral comorbidities: Implication for therapy. Eur. J. Pharmacol. 2018;837:145&#x2013;155. doi: 10.1016/j.ejphar.2018.08.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejphar.2018.08.020</ArticleId><ArticleId IdType="pubmed">30125565</ArticleId></ArticleIdList></Reference><Reference><Citation>Dantzer R., O&#x2019;Connor J.C., Freund G.G., Johnson R.W., Kelley K.W. From inflammation to sickness and depression: When the immune system subjugates the brain. Nat. Rev. Neurosci. 2008;9:46&#x2013;56. doi: 10.1038/nrn2297.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn2297</ArticleId><ArticleId IdType="pmc">PMC2919277</ArticleId><ArticleId IdType="pubmed">18073775</ArticleId></ArticleIdList></Reference><Reference><Citation>Mondelli V., Pariante C.M. What can neuroimmunology teach us about the symptoms of long-COVID? Oxf. Open Immunol. 2021;2:iqab004. doi: 10.1093/oxfimm/iqab004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/oxfimm/iqab004</ArticleId><ArticleId IdType="pmc">PMC7928677</ArticleId><ArticleId IdType="pubmed">34192271</ArticleId></ArticleIdList></Reference><Reference><Citation>Heneka M., Golenbock D., Latz E., Morgan D., Brown R. Immediate and long-term consequences of COVID-19 infections for the development of neurological disease. Alzheimers Res. Ther. 2020;12:69. doi: 10.1186/s13195-020-00640-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13195-020-00640-3</ArticleId><ArticleId IdType="pmc">PMC7271826</ArticleId><ArticleId IdType="pubmed">32498691</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldberg E., Podell K., Sodickson D.K., Fieremans E. The brain after COVID-19: Compensatory neurogenesis or persistent neuroinflammation? EClinicalMedicine. 2021;31:100684. doi: 10.1016/j.eclinm.2020.100684.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2020.100684</ArticleId><ArticleId IdType="pmc">PMC7773850</ArticleId><ArticleId IdType="pubmed">33409480</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazza M.G., Palladini M., De Lorenzo R., Magnaghi C., Poletti S., Furlan R., Ciceri F., Rovere-Querini P., Benedetti F., COVID-19 BioB Outpatient Clinic Study Group Persistent psychopathology and neurocognitive impairment in COVID-19 survivors: Effect of inflammatory biomarkers at three-month follow-up. Brain Behav. Immun. 2021;94:138&#x2013;147. doi: 10.1016/j.bbi.2021.02.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2021.02.021</ArticleId><ArticleId IdType="pmc">PMC7903920</ArticleId><ArticleId IdType="pubmed">33639239</ArticleId></ArticleIdList></Reference><Reference><Citation>Loftis J.M., Firsick E., Shirley K., Adkins J.L., Le-Cook A., Sano E., Hudson R., Moorman J. Inflammatory and mental health sequelae of COVID-19. Compr. Psychoneuroendocrinology. 2023;15:100186. doi: 10.1016/j.cpnec.2023.100186.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cpnec.2023.100186</ArticleId><ArticleId IdType="pmc">PMC10191701</ArticleId><ArticleId IdType="pubmed">37223650</ArticleId></ArticleIdList></Reference><Reference><Citation>Braga J., Lepra M., Kish S.J., Rusjan P.M., Nasser Z., Verhoeff N., Vasdev N., Bagby M., Boileau I., Husain M.I. Neuroinflammation After COVID-19 With Persistent Depressive and Cognitive Symptoms. JAMA Psychiatry. 2023;80:787&#x2013;795. doi: 10.1001/jamapsychiatry.2023.1321.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamapsychiatry.2023.1321</ArticleId><ArticleId IdType="pmc">PMC10233457</ArticleId><ArticleId IdType="pubmed">37256580</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Z., Zhang Z., Zhang Z., Wang Z., Li H. Cognitive impairment after long COVID-19: Current evidence and perspectives. Front. Neurol. 2023;14:1239182. doi: 10.3389/fneur.2023.1239182.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2023.1239182</ArticleId><ArticleId IdType="pmc">PMC10423939</ArticleId><ArticleId IdType="pubmed">37583958</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Hakeim H.K., Al-Rubaye H.T., Al-Hadrawi D.S., Almulla A.F., Maes M. Long-COVID post-viral chronic fatigue and affective symptoms are associated with oxidative damage, lowered antioxidant defenses and inflammation: A proof of concept and mechanism study. Mol. Psychiatry. 2023;28:564&#x2013;578. doi: 10.1038/s41380-022-01836-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41380-022-01836-9</ArticleId><ArticleId IdType="pmc">PMC9589528</ArticleId><ArticleId IdType="pubmed">36280755</ArticleId></ArticleIdList></Reference><Reference><Citation>Bullmore E., Sporns O. The economy of brain network organization. Nat. Rev. Neurosci. 2012;13:336&#x2013;349. doi: 10.1038/nrn3214.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn3214</ArticleId><ArticleId IdType="pubmed">22498897</ArticleId></ArticleIdList></Reference><Reference><Citation>Amzica F., Lopes da Silva F.H. Cellular substrates of brain rhythms. In: Schomer D., Lopes da Silva F.H., editors. Niedermeyer&#x2019;s Electroencephalography: Basic Principles, Clinical Applications, and Related Fields. Lippincott Williams &amp; Wilkins; Philadelphia, PA, USA: 2011. pp. 33&#x2013;63.</Citation></Reference><Reference><Citation>Buzsaki G. Rhythms of the Brain. Oxford University Press; New York, NY, USA: 2006.</Citation></Reference><Reference><Citation>Knight R.T. Neuroscience. Neural networks debunk phrenology. Science. 2007;316:1578&#x2013;1579. doi: 10.1126/science.1144677.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1144677</ArticleId><ArticleId IdType="pubmed">17569852</ArticleId></ArticleIdList></Reference><Reference><Citation>Haider B., Duque A., Hasenstaub A.R., McCormick D.A. Neocortical network activity in vivo is generated through a dynamic balance of excitation and inhibition. J. Neurosci. 2006;26:4535&#x2013;4545. doi: 10.1523/JNEUROSCI.5297-05.2006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.5297-05.2006</ArticleId><ArticleId IdType="pmc">PMC6674060</ArticleId><ArticleId IdType="pubmed">16641233</ArticleId></ArticleIdList></Reference><Reference><Citation>Tatti R., Haley M.S., Swanson O.K., Tselha T., Maffei A. Neurophysiology and Regulation of the Balance Between Excitation and Inhibition in Neocortical Circuits. Biol. Psychiatry. 2017;81:821&#x2013;831. doi: 10.1016/j.biopsych.2016.09.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopsych.2016.09.017</ArticleId><ArticleId IdType="pmc">PMC5374043</ArticleId><ArticleId IdType="pubmed">27865453</ArticleId></ArticleIdList></Reference><Reference><Citation>Rubenstein J.L., Merzenich M.M. Model of autism: Increased ratio of excitation/inhibition in key neural systems. Genes. Brain Behav. 2003;2:255&#x2013;267. doi: 10.1034/j.1601-183X.2003.00037.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1034/j.1601-183X.2003.00037.x</ArticleId><ArticleId IdType="pmc">PMC6748642</ArticleId><ArticleId IdType="pubmed">14606691</ArticleId></ArticleIdList></Reference><Reference><Citation>Sohal V.S., Rubenstein J.L. Excitation-inhibition balance as a framework for investigating mechanisms in neuropsychiatric disorders. Mol. Psychiatry. 2019;24:1248&#x2013;1257. doi: 10.1038/s41380-019-0426-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41380-019-0426-0</ArticleId><ArticleId IdType="pmc">PMC6742424</ArticleId><ArticleId IdType="pubmed">31089192</ArticleId></ArticleIdList></Reference><Reference><Citation>Selten M., van Bokhoven H., Nadif Kasri N. Inhibitory control of the excitatory/inhibitory balance in psychiatric disorders. F1000Res. 2018;7:23. doi: 10.12688/f1000research.12155.1.</Citation><ArticleIdList><ArticleId IdType="doi">10.12688/f1000research.12155.1</ArticleId><ArticleId IdType="pmc">PMC5760969</ArticleId><ArticleId IdType="pubmed">29375819</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao R., Penzes P. Common mechanisms of excitatory and inhibitory imbalance in schizophrenia and autism spectrum disorders. Curr. Mol. Med. 2015;15:146&#x2013;167. doi: 10.2174/1566524015666150303003028.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1566524015666150303003028</ArticleId><ArticleId IdType="pmc">PMC4721588</ArticleId><ArticleId IdType="pubmed">25732149</ArticleId></ArticleIdList></Reference><Reference><Citation>Marin O. Interneuron dysfunction in psychiatric disorders. Nat. Rev. Neurosci. 2012;13:107&#x2013;120. doi: 10.1038/nrn3155.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn3155</ArticleId><ArticleId IdType="pubmed">22251963</ArticleId></ArticleIdList></Reference><Reference><Citation>Nunez P.L., Srinivasan R. Electric Fields of the Brain: The Neurophysics of EEG. Oxford University Press; New York, NY, USA: 2006.</Citation></Reference><Reference><Citation>Prichard J.W., Shulman R.G. NMR spectroscopy of brain metabolism in vivo. Annu. Rev. Neurosci. 1986;9:61&#x2013;85. doi: 10.1146/annurev.ne.09.030186.000425.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.ne.09.030186.000425</ArticleId><ArticleId IdType="pubmed">2871798</ArticleId></ArticleIdList></Reference><Reference><Citation>Radda G.K., Rajagopalan B., Taylor D.J. Biochemistry in vivo: An appraisal of clinical magnetic resonance spectroscopy. Magn. Reson. Q. 1989;5:122&#x2013;151.</Citation><ArticleIdList><ArticleId IdType="pubmed">2701278</ArticleId></ArticleIdList></Reference><Reference><Citation>Bluml S. Magnetic resonance spectroscopy: Basics. In: Bluml S., Panigrahy A., editors. MR Spectroscopy of Pediatric Brain Disorders. Springer; New York, NY, USA: 2012. pp. 11&#x2013;23.</Citation></Reference><Reference><Citation>Cox I.J. Development and applications of in vivo clinical magnetic resonance spectroscopy. Prog. Biophys. Mol. Biol. 1996;65:45&#x2013;81. doi: 10.1016/S0079-6107(96)00006-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0079-6107(96)00006-5</ArticleId><ArticleId IdType="pubmed">9029941</ArticleId></ArticleIdList></Reference><Reference><Citation>Ende G. Proton Magnetic Resonance Spectroscopy: Relevance of Glutamate and GABA to Neuropsychology. Neuropsychol. Rev. 2015;25:315&#x2013;325. doi: 10.1007/s11065-015-9295-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11065-015-9295-8</ArticleId><ArticleId IdType="pubmed">26264407</ArticleId></ArticleIdList></Reference><Reference><Citation>Harris A.D., Saleh M.G., Edden R.A. Edited (1) H magnetic resonance spectroscopy in vivo: Methods and metabolites. Magn. Reson. Med. 2017;77:1377&#x2013;1389. doi: 10.1002/mrm.26619.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mrm.26619</ArticleId><ArticleId IdType="pmc">PMC5352552</ArticleId><ArticleId IdType="pubmed">28150876</ArticleId></ArticleIdList></Reference><Reference><Citation>Koh W., Kwak H., Cheong E., Lee C.J. GABA tone regulation and its cognitive functions in the brain. Nat. Rev. Neurosci. 2023;24:523&#x2013;539. doi: 10.1038/s41583-023-00724-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41583-023-00724-7</ArticleId><ArticleId IdType="pubmed">37495761</ArticleId></ArticleIdList></Reference><Reference><Citation>Tremblay R., Lee S., Rudy B. GABAergic interneurons in the neocortex: From cellular properties to circuits. Neuron. 2016;91:260&#x2013;292. doi: 10.1016/j.neuron.2016.06.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2016.06.033</ArticleId><ArticleId IdType="pmc">PMC4980915</ArticleId><ArticleId IdType="pubmed">27477017</ArticleId></ArticleIdList></Reference><Reference><Citation>Markram H., Toledo-Rodriguez M., Wang Y., Gupta A., Silberberg G., Wu C. Interneurons of the neocortical inhibitory system. Nat. Rev. Neurosci. 2004;5:793&#x2013;807. doi: 10.1038/nrn1519.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn1519</ArticleId><ArticleId IdType="pubmed">15378039</ArticleId></ArticleIdList></Reference><Reference><Citation>Roux L., Buzsaki G. Tasks for inhibitory interneurons in intact brain circuits. Neuropharmacology. 2015;88:10&#x2013;23. doi: 10.1016/j.neuropharm.2014.09.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuropharm.2014.09.011</ArticleId><ArticleId IdType="pmc">PMC4254329</ArticleId><ArticleId IdType="pubmed">25239808</ArticleId></ArticleIdList></Reference><Reference><Citation>DeFelipe J., Alonso-Nanclares L., Arellano J.I. Microstructure of the neocortex: Comparative aspects. J. Neurocytol. 2002;31:299&#x2013;316. doi: 10.1023/A:1024130211265.</Citation><ArticleIdList><ArticleId IdType="doi">10.1023/A:1024130211265</ArticleId><ArticleId IdType="pubmed">12815249</ArticleId></ArticleIdList></Reference><Reference><Citation>Kolasinski J., Logan J.P., Hinson E.L., Manners D., Zand A.P.D., Makin T.R., Emir U.E., Stagg C.J. A mechanistic link from GABA to cortical architecture and perception. Curr. Biol. 2017;27:1685&#x2013;1691.e1683. doi: 10.1016/j.cub.2017.04.055.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cub.2017.04.055</ArticleId><ArticleId IdType="pmc">PMC5462622</ArticleId><ArticleId IdType="pubmed">28552355</ArticleId></ArticleIdList></Reference><Reference><Citation>Yizhar O., Fenno L.E., Prigge M., Schneider F., Davidson T.J., O&#x2019;Shea D.J., Sohal V.S., Goshen I., Finkelstein J., Paz J.T., et al. Neocortical excitation/inhibition balance in information processing and social dysfunction. Nature. 2011;477:171&#x2013;178. doi: 10.1038/nature10360.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature10360</ArticleId><ArticleId IdType="pmc">PMC4155501</ArticleId><ArticleId IdType="pubmed">21796121</ArticleId></ArticleIdList></Reference><Reference><Citation>Schur R.R., Draisma L.W., Wijnen J.P., Boks M.P., Koevoets M.G., Joels M., Klomp D.W., Kahn R.S., Vinkers C.H. Brain GABA levels across psychiatric disorders: A systematic literature review and meta-analysis of (1) H-MRS studies. Hum. Brain Mapp. 2016;37:3337&#x2013;3352. doi: 10.1002/hbm.23244.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hbm.23244</ArticleId><ArticleId IdType="pmc">PMC6867515</ArticleId><ArticleId IdType="pubmed">27145016</ArticleId></ArticleIdList></Reference><Reference><Citation>Mescher M., Merkle H., Kirsch J., Garwood M., Gruetter R. Simultaneous in vivo spectral editing and water suppression. NMR Biomed. 1998;11:266&#x2013;272. doi: 10.1002/(SICI)1099-1492(199810)11:6&lt;266::AID-NBM530&gt;3.0.CO;2-J.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/(SICI)1099-1492(199810)11:6&lt;266::AID-NBM530&gt;3.0.CO;2-J</ArticleId><ArticleId IdType="pubmed">9802468</ArticleId></ArticleIdList></Reference><Reference><Citation>Petroff O.A., Hyder F., Rothman D.L., Mattson R.H. Homocarnosine and seizure control in juvenile myoclonic epilepsy and complex partial seizures. Neurology. 2001;56:709&#x2013;715. doi: 10.1212/WNL.56.6.709.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.56.6.709</ArticleId><ArticleId IdType="pubmed">11274303</ArticleId></ArticleIdList></Reference><Reference><Citation>Marinkovic K., Alderson Myers A.B., Arienzo D., Sereno M.I., Mason G.F. Cortical GABA levels are reduced in young adult binge drinkers: Association with recent alcohol consumption and sex. Neuroimage Clin. 2022;35:103091. doi: 10.1016/j.nicl.2022.103091.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nicl.2022.103091</ArticleId><ArticleId IdType="pmc">PMC9240858</ArticleId><ArticleId IdType="pubmed">35753236</ArticleId></ArticleIdList></Reference><Reference><Citation>Rae C.D. A guide to the metabolic pathways and function of metabolites observed in human brain 1H magnetic resonance spectra. Neurochem. Res. 2014;39:1&#x2013;36. doi: 10.1007/s11064-013-1199-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11064-013-1199-5</ArticleId><ArticleId IdType="pubmed">24258018</ArticleId></ArticleIdList></Reference><Reference><Citation>Saleh M.G., Chang L., Liang H., Ryan M.C., Cunningham E., Garner J., Wilson E., Levine A.R., Kottilil S., Ernst T. Ongoing oxidative stress in individuals with post-acute sequelae of COVID-19. Neuroimmune Pharmacol. Ther. 2023;2:89&#x2013;94. doi: 10.1515/nipt-2022-0006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/nipt-2022-0006</ArticleId><ArticleId IdType="pmc">PMC10355326</ArticleId><ArticleId IdType="pubmed">37476292</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanacora G., Mason G.F., Krystal J.H. Impairment of GABAergic transmission in depression: New insights from neuroimaging studies. Crit. Rev. Neurobiol. 2000;14:23&#x2013;45. doi: 10.1615/CritRevNeurobiol.v14.i1.20.</Citation><ArticleIdList><ArticleId IdType="doi">10.1615/CritRevNeurobiol.v14.i1.20</ArticleId><ArticleId IdType="pubmed">11253954</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanacora G., Gueorguieva R., Epperson C.N., Wu Y.-T., Appel M., Rothman D.L., Krystal J.H., Mason G.F. Subtype-specific alterations of &#x3b3;-aminobutyric acid and glutamatein patients with major depression. Arch. Gen. Psychiat. 2004;61:705&#x2013;713. doi: 10.1001/archpsyc.61.7.705.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archpsyc.61.7.705</ArticleId><ArticleId IdType="pubmed">15237082</ArticleId></ArticleIdList></Reference><Reference><Citation>Hasler G., van der Veen J.W., Tumonis T., Meyers N., Shen J., Drevets W.C. Reduced prefrontal glutamate/glutamine and &#x3b3;-aminobutyric acid levels in major depression determined using proton magnetic resonance spectroscopy. Arch. Gen. Psychiat. 2007;64:193&#x2013;200. doi: 10.1001/archpsyc.64.2.193.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archpsyc.64.2.193</ArticleId><ArticleId IdType="pubmed">17283286</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhagwagar Z., Wylezinska M., Jezzard P., Evans J., Ashworth F., Sule A., Matthews P.M., Cowen P.J. Reduction in occipital cortex &#x3b3;-aminobutyric acid concentrations in medication-free recovered unipolar depressed and bipolar subjects. Biol. Psychiat. 2007;61:806&#x2013;812. doi: 10.1016/j.biopsych.2006.08.048.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopsych.2006.08.048</ArticleId><ArticleId IdType="pubmed">17210135</ArticleId></ArticleIdList></Reference><Reference><Citation>Price R.B., Shungu D.C., Mao X., Nestadt P., Kelly C., Collins K.A., Murrough J.W., Charney D.S., Mathew S.J. Amino acid neurotransmitters assessed by 1H MRS: Relationship to treatment-resistance in major depressive disorder. Biol. Psychiat. 2009;65:792. doi: 10.1016/j.biopsych.2008.10.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopsych.2008.10.025</ArticleId><ArticleId IdType="pmc">PMC2934870</ArticleId><ArticleId IdType="pubmed">19058788</ArticleId></ArticleIdList></Reference><Reference><Citation>Crowley T., Cryan J.F., Downer E.J., O&#x2019;Leary O.F. Inhibiting neuroinflammation: The role and therapeutic potential of GABA in neuro-immune interactions. Brain Behav. Immun. 2016;54:260&#x2013;277. doi: 10.1016/j.bbi.2016.02.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2016.02.001</ArticleId><ArticleId IdType="pubmed">26851553</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian J., Kaufman D.L. The GABA and GABA-Receptor System in Inflammation, Anti-Tumor Immune Responses, and COVID-19. Biomedicines. 2023;11:254. doi: 10.3390/biomedicines11020254.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines11020254</ArticleId><ArticleId IdType="pmc">PMC9953446</ArticleId><ArticleId IdType="pubmed">36830790</ArticleId></ArticleIdList></Reference><Reference><Citation>Sklinda K., G&#xf3;recki A., Dorobek M., Walecki J., Modrzy&#x144;ska A., Mruk B. Ischaemic background of brain fog in long haul COVID-19&#x2013;a nuclear magnetic resonance spectroscopy-based metabonomic analysis. Preliminary results. Pol. J. Radiol. 2021;86:654&#x2013;660. doi: 10.5114/pjr.2021.111100.</Citation><ArticleIdList><ArticleId IdType="doi">10.5114/pjr.2021.111100</ArticleId><ArticleId IdType="pmc">PMC8757010</ArticleId><ArticleId IdType="pubmed">35059058</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramadan S., Lin A., Stanwell P. Glutamate and glutamine: A review of in vivo MRS in the human brain. NMR Biomed. 2013;26:1630&#x2013;1646. doi: 10.1002/nbm.3045.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/nbm.3045</ArticleId><ArticleId IdType="pmc">PMC3849600</ArticleId><ArticleId IdType="pubmed">24123328</ArticleId></ArticleIdList></Reference><Reference><Citation>Inglese M., Rusinek H., George I.C., Babb J.S., Grossman R.I., Gonen O. Global average gray and white matter N-acetylaspartate concentration in the human brain. Neuroimage. 2008;41:270&#x2013;276. doi: 10.1016/j.neuroimage.2008.02.034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroimage.2008.02.034</ArticleId><ArticleId IdType="pmc">PMC2486451</ArticleId><ArticleId IdType="pubmed">18400521</ArticleId></ArticleIdList></Reference><Reference><Citation>Urenjak J., Williams S.R., Gadian D.G., Noble M. Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types. J. Neurosci. 1993;13:981&#x2013;989. doi: 10.1523/JNEUROSCI.13-03-00981.1993.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.13-03-00981.1993</ArticleId><ArticleId IdType="pmc">PMC6576593</ArticleId><ArticleId IdType="pubmed">8441018</ArticleId></ArticleIdList></Reference><Reference><Citation>Moffett J.R., Ross B., Arun P., Madhavarao C.N., Namboodiri A.M. N-Acetylaspartate in the CNS: From neurodiagnostics to neurobiology. Prog. Neurobiol. 2007;81:89&#x2013;131. doi: 10.1016/j.pneurobio.2006.12.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pneurobio.2006.12.003</ArticleId><ArticleId IdType="pmc">PMC1919520</ArticleId><ArticleId IdType="pubmed">17275978</ArticleId></ArticleIdList></Reference><Reference><Citation>Sullivan E.V., Adalsteinsson E., Spielman D.M., Hurd R.E., Pfefferbaum A. N-acetylaspartate&#x2014;A marker of neuronal integrity. Ann. Neurol. 2001;50:823. doi: 10.1002/ana.1279.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.1279</ArticleId><ArticleId IdType="pubmed">11761485</ArticleId></ArticleIdList></Reference><Reference><Citation>Joyce J.M., La P.L., Walker R., Harris A.D. Magnetic resonance spectroscopy of traumatic brain injury and subconcussive hits: A systematic review and meta&#x2013;analysis. J. Neurotrauma. 2022;39:1455&#x2013;1476. doi: 10.1089/neu.2022.0125.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/neu.2022.0125</ArticleId><ArticleId IdType="pmc">PMC9689773</ArticleId><ArticleId IdType="pubmed">35838132</ArticleId></ArticleIdList></Reference><Reference><Citation>Kong L., Li H., Lin F., Zheng W., Zhang H., Wu R. Neurochemical and microstructural alterations in bipolar and depressive disorders: A multimodal magnetic resonance imaging study. Front. Neurol. 2023;14:1089067. doi: 10.3389/fneur.2023.1089067.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2023.1089067</ArticleId><ArticleId IdType="pmc">PMC10014904</ArticleId><ArticleId IdType="pubmed">36937532</ArticleId></ArticleIdList></Reference><Reference><Citation>Li H., Xu H., Zhang Y., Guan J., Zhang J., Xu C., Shen Z., Xiao B., Liang C., Chen K. Differential neurometabolite alterations in brains of medication-free individuals with bipolar disorder and those with unipolar depression: A two-dimensional proton magnetic resonance spectroscopy study. Bipolar Disord. 2016;18:583&#x2013;590. doi: 10.1111/bdi.12445.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bdi.12445</ArticleId><ArticleId IdType="pubmed">27870506</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang L., Munsaka S.M., Kraft-Terry S., Ernst T. Magnetic resonance spectroscopy to assess neuroinflammation and neuropathic pain. J. Neuroimmune Pharmacol. 2013;8:576&#x2013;593. doi: 10.1007/s11481-013-9460-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11481-013-9460-x</ArticleId><ArticleId IdType="pmc">PMC3698315</ArticleId><ArticleId IdType="pubmed">23666436</ArticleId></ArticleIdList></Reference><Reference><Citation>Paslakis G., Tr&#xe4;ber F., Roberz J., Block W., Jessen F. N-acetyl-aspartate (NAA) as a correlate of pharmacological treatment in psychiatric disorders: A systematic review. Eur. Neuropsychopharmacol. 2014;24:1659&#x2013;1675. doi: 10.1016/j.euroneuro.2014.06.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.euroneuro.2014.06.004</ArticleId><ArticleId IdType="pubmed">25130303</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinson R.T., Drafts B.C., Fisher J.L. Fluoxetine increases GABAA receptor activity through a novel modulatory site. J. Pharmacol. Exp. Ther. 2003;304:978&#x2013;984. doi: 10.1124/jpet.102.044834.</Citation><ArticleIdList><ArticleId IdType="doi">10.1124/jpet.102.044834</ArticleId><ArticleId IdType="pubmed">12604672</ArticleId></ArticleIdList></Reference><Reference><Citation>Pereira F.C., Rolo M.R., Marques E., Mendes V.M., Ribeiro C.F., Ali S.F., Morgadinho T., Macedo T.R. Acute increase of the glutamate&#x2013;glutamine cycling in discrete brain areas after administration of a single dose of amphetamine. Ann. N. Y. Acad. Sci. 2008;1139:212&#x2013;221. doi: 10.1196/annals.1432.040.</Citation><ArticleIdList><ArticleId IdType="doi">10.1196/annals.1432.040</ArticleId><ArticleId IdType="pubmed">18991867</ArticleId></ArticleIdList></Reference><Reference><Citation>Klok F.A., Boon G., Barco S., Endres M., Geelhoed J.J.M., Knauss S., Rezek S.A., Spruit M.A., Vehreschild J., Siegerink B. The Post-COVID-19 Functional Status scale: A tool to measure functional status over time after COVID-19. Eur. Respir. J. 2020;56:2001494. doi: 10.1183/13993003.01494-2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.01494-2020</ArticleId><ArticleId IdType="pmc">PMC7236834</ArticleId><ArticleId IdType="pubmed">32398306</ArticleId></ArticleIdList></Reference><Reference><Citation>Premraj L., Kannapadi N.V., Briggs J., Seal S.M., Battaglini D., Fanning J., Suen J., Robba C., Fraser J., Cho S.-M. Mid and long-term neurological and neuropsychiatric manifestations of post-COVID-19 syndrome: A meta-analysis. J. Neurol. Sci. 2022;434:120162. doi: 10.1016/j.jns.2022.120162.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2022.120162</ArticleId><ArticleId IdType="pmc">PMC8798975</ArticleId><ArticleId IdType="pubmed">35121209</ArticleId></ArticleIdList></Reference><Reference><Citation>Han Q., Zheng B., Daines L., Sheikh A. Long-term sequelae of COVID-19: A systematic review and meta-analysis of one-year follow-up studies on post-COVID symptoms. Pathogens. 2022;11:269. doi: 10.3390/pathogens11020269.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathogens11020269</ArticleId><ArticleId IdType="pmc">PMC8875269</ArticleId><ArticleId IdType="pubmed">35215212</ArticleId></ArticleIdList></Reference><Reference><Citation>Jennings G., Monaghan A., Xue F., Mockler D., Romero-Ortu&#xf1;o R. A systematic review of persistent symptoms and residual abnormal functioning following acute COVID-19: Ongoing symptomatic phase vs. post-COVID-19 syndrome. J. Clin. Med. 2021;10:5913. doi: 10.3390/jcm10245913.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10245913</ArticleId><ArticleId IdType="pmc">PMC8708187</ArticleId><ArticleId IdType="pubmed">34945213</ArticleId></ArticleIdList></Reference><Reference><Citation>Carle A.C., Riley W., Hays R.D., Cella D. Confirmatory Factor Analysis of the Patient Reported Outcomes Measurement Information System (PROMIS) Adult Domain Framework Using Item Response Theory Scores. Med. Care. 2015;53:894&#x2013;900. doi: 10.1097/MLR.0000000000000413.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MLR.0000000000000413</ArticleId><ArticleId IdType="pmc">PMC4750392</ArticleId><ArticleId IdType="pubmed">26366521</ArticleId></ArticleIdList></Reference><Reference><Citation>Rogers J.P., Chesney E., Oliver D., Pollak T.A., McGuire P., Fusar-Poli P., Zandi M.S., Lewis G., David A.S. Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: A systematic review and meta-analysis with comparison to the COVID-19 pandemic. Lancet Psychiatry. 2020;7:611&#x2013;627. doi: 10.1016/S2215-0366(20)30203-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(20)30203-0</ArticleId><ArticleId IdType="pmc">PMC7234781</ArticleId><ArticleId IdType="pubmed">32437679</ArticleId></ArticleIdList></Reference><Reference><Citation>Kratz A.L., Schilling S.G., Goesling J., Williams D.A. Development and initial validation of a brief self-report measure of cognitive dysfunction in fibromyalgia. J. Pain. 2015;16:527&#x2013;536. doi: 10.1016/j.jpain.2015.02.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpain.2015.02.008</ArticleId><ArticleId IdType="pmc">PMC4456217</ArticleId><ArticleId IdType="pubmed">25746197</ArticleId></ArticleIdList></Reference><Reference><Citation>Rubega M., Ciringione L., Bertuccelli M., Paramento M., Sparacino G., Vianello A., Masiero S., Vallesi A., Formaggio E., Del Felice A. High-density EEG sleep correlates of cognitive and affective impairment at 12-month follow-up after COVID-19. Clin. Neurophysiol. 2022;140:126&#x2013;135. doi: 10.1016/j.clinph.2022.05.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinph.2022.05.017</ArticleId><ArticleId IdType="pmc">PMC9292469</ArticleId><ArticleId IdType="pubmed">35763985</ArticleId></ArticleIdList></Reference><Reference><Citation>Saucier J., Jose C., Beroual Z., Al-Qadi M., Chartrand S., Libert E., Losier M.-C., Cooling K., Girouard G., Jbilou J. Cognitive inhibition deficit in long COVID-19: An exploratory study. Front. Neurol. 2023;14:1125574. doi: 10.3389/fneur.2023.1125574.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2023.1125574</ArticleId><ArticleId IdType="pmc">PMC10140516</ArticleId><ArticleId IdType="pubmed">37122293</ArticleId></ArticleIdList></Reference><Reference><Citation>Rothrock N., Amtmann D., Cook K. Development and validation of an interpretive guide for PROMIS scores. J. Patient Rep. Outcomes. 2020;4:16. doi: 10.1186/s41687-020-0181-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s41687-020-0181-7</ArticleId><ArticleId IdType="pmc">PMC7048882</ArticleId><ArticleId IdType="pubmed">32112189</ArticleId></ArticleIdList></Reference><Reference><Citation>Percze A.R., Nagy A., Polivka L., Barczi E., Czaller I., Kovats Z., Varga J.T., Ballai J.H., Muller V., Horvath G. Fatigue, sleepiness and sleep quality are SARS-CoV-2 variant independent in patients with long COVID symptoms. Inflammopharmacology. 2023:1&#x2013;7. doi: 10.1007/s10787-023-01190-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10787-023-01190-4</ArticleId><ArticleId IdType="pmc">PMC10075170</ArticleId><ArticleId IdType="pubmed">37020055</ArticleId></ArticleIdList></Reference><Reference><Citation>Nowakowski S., Kokonda M., Sultana R., Duong B.B., Nagy S.E., Zaidan M.F., Baig M.M., Grigg B.V., Seashore J., Deer R.R. Association between sleep quality and mental health among patients at a post-COVID-19 recovery clinic. Brain Sci. 2022;12:586. doi: 10.3390/brainsci12050586.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/brainsci12050586</ArticleId><ArticleId IdType="pmc">PMC9139253</ArticleId><ArticleId IdType="pubmed">35624973</ArticleId></ArticleIdList></Reference><Reference><Citation>Lauria A., Carf&#xec; A., Benvenuto F., Bramato G., Ciciarello F., Rocchi S., Rota E., Salerno A., Stella L., Tritto M. Neuropsychological measures of post-COVID-19 cognitive status. Front. Psychol. 2023;14:1136667. doi: 10.3389/fpsyg.2023.1136667.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpsyg.2023.1136667</ArticleId><ArticleId IdType="pmc">PMC10363721</ArticleId><ArticleId IdType="pubmed">37492442</ArticleId></ArticleIdList></Reference><Reference><Citation>Kerr W.C., Ye Y., Martinez P., Karriker-Jaffe K.J., Patterson D., Greenfield T.K., Mulia N. Longitudinal assessment of drinking changes during the pandemic: The 2021 COVID-19 follow-up study to the 2019 to 2020 National Alcohol Survey. Alcohol. Clin. Exp. Res. 2022;46:1050&#x2013;1061. doi: 10.1111/acer.14839.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/acer.14839</ArticleId><ArticleId IdType="pmc">PMC9350305</ArticleId><ArticleId IdType="pubmed">35753040</ArticleId></ArticleIdList></Reference><Reference><Citation>Castaldelli-Maia J.M., Segura L.E., Martins S.S. The concerning increasing trend of alcohol beverage sales in the US during the COVID-19 pandemic. Alcohol. 2021;96:37&#x2013;42. doi: 10.1016/j.alcohol.2021.06.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.alcohol.2021.06.004</ArticleId><ArticleId IdType="pmc">PMC8421038</ArticleId><ArticleId IdType="pubmed">34245809</ArticleId></ArticleIdList></Reference><Reference><Citation>QualtricsXM.  [(accessed on 30 June 2023)].  Available online:  https://www.qualtrics.com/</Citation></Reference><Reference><Citation>Brown J.M., Lansdall C.J., Wiggins J., Dawson K.E., Hunter K., Rowe J.B., Parker R.A. The Test Your Memory for Mild Cognitive Impairment (TYM-MCI) J. Neurol. Neurosurg. Psychiatry. 2017;88:1045&#x2013;1051. doi: 10.1136/jnnp-2016-315327.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2016-315327</ArticleId><ArticleId IdType="pmc">PMC5740554</ArticleId><ArticleId IdType="pubmed">28912299</ArticleId></ArticleIdList></Reference><Reference><Citation>Wechsler D. Wechsler Abbreviated Scale of Intelligence (WASI&#x2014;II) The Psychological Corporation; San Antonio, TX, USA: 1999.</Citation></Reference><Reference><Citation>Cohen S., Kamarck T., Mermelstein R. A global measure of perceived stress. J. Health Soc. Behav. 1983;24:385&#x2013;396. doi: 10.2307/2136404.</Citation><ArticleIdList><ArticleId IdType="doi">10.2307/2136404</ArticleId><ArticleId IdType="pubmed">6668417</ArticleId></ArticleIdList></Reference><Reference><Citation>Buysse D.J., Reynolds C.F., 3rd, Monk T.H., Berman S.R., Kupfer D.J. The Pittsburgh Sleep Quality Index: A new instrument for psychiatric practice and research. Psychiatry Res. 1989;28:193&#x2013;213. doi: 10.1016/0165-1781(89)90047-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0165-1781(89)90047-4</ArticleId><ArticleId IdType="pubmed">2748771</ArticleId></ArticleIdList></Reference><Reference><Citation>Coutlee C.G., Politzer C.S., Hoyle R.H., Huettel S.A. An abbreviated impulsiveness scale constructed through confirmatory factor analysis of the Barratt Impulsiveness Scale version 11. Arch. Sci. Psychol. 2014;2:1&#x2013;12. doi: 10.1037/arc0000005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1037/arc0000005</ArticleId><ArticleId IdType="pmc">PMC4527550</ArticleId><ArticleId IdType="pubmed">26258000</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoyle R.H., Stephenson M.T., Palmgreen P., Lorch E.P., Donohew R.L. Reliability and validity of a brief measure of sensation seeking. Pers. Indiv. Differ. 2002;32:401&#x2013;414. doi: 10.1016/S0191-8869(01)00032-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0191-8869(01)00032-0</ArticleId></ArticleIdList></Reference><Reference><Citation>Spitzer R.L., Kroenke K., Williams J.B., Lowe B. A brief measure for assessing generalized anxiety disorder: The GAD-7. Arch. Intern. Med. 2006;166:1092&#x2013;1097. doi: 10.1001/archinte.166.10.1092.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archinte.166.10.1092</ArticleId><ArticleId IdType="pubmed">16717171</ArticleId></ArticleIdList></Reference><Reference><Citation>Kroenke K., Spitzer R.L. The PHQ-9: A new depression diagnostic and severity measure. Psychiatr. Ann. 2002;32:509&#x2013;515. doi: 10.3928/0048-5713-20020901-06.</Citation><ArticleIdList><ArticleId IdType="doi">10.3928/0048-5713-20020901-06</ArticleId></ArticleIdList></Reference><Reference><Citation>Mullins P.G., Chen H., Xu J., Caprihan A., Gasparovic C. Comparative reliability of proton spectroscopy techniques designed to improve detection of J-coupled metabolites. Magn. Reson. Med. 2008;60:964&#x2013;969. doi: 10.1002/mrm.21696.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mrm.21696</ArticleId><ArticleId IdType="pubmed">18816817</ArticleId></ArticleIdList></Reference><Reference><Citation>Mikkelsen M., Loo R.S., Puts N.A.J., Edden R.A.E., Harris A.D. Designing GABA-edited magnetic resonance spectroscopy studies: Considerations of scan duration, signal-to-noise ratio and sample size. J. Neurosci. Methods. 2018;303:86&#x2013;94. doi: 10.1016/j.jneumeth.2018.02.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jneumeth.2018.02.012</ArticleId><ArticleId IdType="pmc">PMC5940501</ArticleId><ArticleId IdType="pubmed">29476871</ArticleId></ArticleIdList></Reference><Reference><Citation>Edden R.A., Puts N.A., Harris A.D., Barker P.B., Evans C.J. Gannet: A batch-processing tool for the quantitative analysis of gamma-aminobutyric acid-edited MR spectroscopy spectra. J. Magn. Reson. Imaging. 2014;40:1445&#x2013;1452. doi: 10.1002/jmri.24478.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmri.24478</ArticleId><ArticleId IdType="pmc">PMC4280680</ArticleId><ArticleId IdType="pubmed">25548816</ArticleId></ArticleIdList></Reference><Reference><Citation>Cuypers K., Hehl M., van Aalst J., Chalavi S., Mikkelsen M., Van Laere K., Dupont P., Mantini D., Swinnen S.P. Age-related GABAergic differences in the primary sensorimotor cortex: A multimodal approach combining PET, MRS and TMS. Neuroimage. 2021;226:117536. doi: 10.1016/j.neuroimage.2020.117536.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroimage.2020.117536</ArticleId><ArticleId IdType="pmc">PMC7894275</ArticleId><ArticleId IdType="pubmed">33186716</ArticleId></ArticleIdList></Reference><Reference><Citation>Puts N.A.J., Heba S., Harris A.D., Evans C.J., McGonigle D.J., Tegenthoff M., Schmidt-Wilcke T., Edden R.A.E. GABA Levels in Left and Right Sensorimotor Cortex Correlate across Individuals. Biomedicines. 2018;6:80. doi: 10.3390/biomedicines6030080.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines6030080</ArticleId><ArticleId IdType="pmc">PMC6164430</ArticleId><ArticleId IdType="pubmed">30042306</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhagwagar Z., Wylezinska M., Taylor M., Jezzard P., Matthews P.M., Cowen P.J. Increased brain GABA concentrations following acute administration of a selective serotonin reuptake inhibitor. Am. J. Psychiatry. 2004;161:368&#x2013;370. doi: 10.1176/appi.ajp.161.2.368.</Citation><ArticleIdList><ArticleId IdType="doi">10.1176/appi.ajp.161.2.368</ArticleId><ArticleId IdType="pubmed">14754790</ArticleId></ArticleIdList></Reference><Reference><Citation>Peek A., Rebbeck T., Leaver A., Foster S.L., Refshauge K., Puts N., Oeltzschner G., Andronesi O.C., Barker P.B., Bogner W. A comprehensive guide to MEGA-PRESS for GABA measurement. Anal. Biochem. 2023;669:115113. doi: 10.1016/j.ab.2023.115113.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ab.2023.115113</ArticleId><ArticleId IdType="pubmed">36958511</ArticleId></ArticleIdList></Reference><Reference><Citation>Gasparovic C., Song T., Devier D., Bockholt H.J., Caprihan A., Mullins P.G., Posse S., Jung R.E., Morrison L.A. Use of tissue water as a concentration reference for proton spectroscopic imaging. Magn. Reson. Med. 2006;55:1219&#x2013;1226. doi: 10.1002/mrm.20901.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mrm.20901</ArticleId><ArticleId IdType="pubmed">16688703</ArticleId></ArticleIdList></Reference><Reference><Citation>Mullins P.G., McGonigle D.J., O&#x2019;Gorman R.L., Puts N.A., Vidyasagar R., Evans C.J., Cardiff Symposium on MRS of GABA. Edden R.A. Current practice in the use of MEGA-PRESS spectroscopy for the detection of GABA. Neuroimage. 2014;86:43&#x2013;52. doi: 10.1016/j.neuroimage.2012.12.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroimage.2012.12.004</ArticleId><ArticleId IdType="pmc">PMC3825742</ArticleId><ArticleId IdType="pubmed">23246994</ArticleId></ArticleIdList></Reference><Reference><Citation>SPSS . IBM SPSS Statistics for Windows. SPSS Inc.; Chicago, IL, USA: 2017.</Citation></Reference><Reference><Citation>MacKinnon D.P., Fairchild A.J., Fritz M.S. Mediation analysis. Annu. Rev. Psychol. 2007;58:593&#x2013;614. doi: 10.1146/annurev.psych.58.110405.085542.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.psych.58.110405.085542</ArticleId><ArticleId IdType="pmc">PMC2819368</ArticleId><ArticleId IdType="pubmed">16968208</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayes A.F. Beyond Baron and Kenny: Statistical mediation analysis in the new millennium. Commun. Monogr. 2009;76:408&#x2013;420. doi: 10.1080/03637750903310360.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/03637750903310360</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheetham N.J., Penfold R., Giunchiglia V., Bowyer V., Sudre C.H., Canas L.S., Deng J., Murray B., Kerfoot E., Antonelli M. The effects of COVID-19 on cognitive performance in a community-based cohort: A COVID symptom study biobank prospective cohort study. EClinicalMedicine. 2023;62:102086. doi: 10.1016/j.eclinm.2023.102086.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2023.102086</ArticleId><ArticleId IdType="pmc">PMC10466229</ArticleId><ArticleId IdType="pubmed">37654669</ArticleId></ArticleIdList></Reference><Reference><Citation>Du Y., Zhao W., Huang S., Huang Y., Chen Y., Zhang H., Guo H., Liu J. Two-year follow-up of brain structural changes in patients who recovered from COVID-19: A prospective study. Psychiatry Res. 2023;319:114969. doi: 10.1016/j.psychres.2022.114969.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.psychres.2022.114969</ArticleId><ArticleId IdType="pmc">PMC9684092</ArticleId><ArticleId IdType="pubmed">36462292</ArticleId></ArticleIdList></Reference><Reference><Citation>Nouraeinejad A. Brain fog as a Long-term Sequela of COVID-19. SN Compr. Clin. Med. 2022;5:9. doi: 10.1007/s42399-022-01352-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s42399-022-01352-5</ArticleId><ArticleId IdType="pmc">PMC9685075</ArticleId><ArticleId IdType="pubmed">36466122</ArticleId></ArticleIdList></Reference><Reference><Citation>Stefanou M.-I., Palaiodimou L., Bakola E., Smyrnis N., Papadopoulou M., Paraskevas G.P., Rizos E., Boutati E., Grigoriadis N., Krogias C. Neurological manifestations of long-COVID syndrome: A narrative review. Ther. Adv. Chronic Dis. 2022;13:20406223221076890. doi: 10.1177/20406223221076890.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/20406223221076890</ArticleId><ArticleId IdType="pmc">PMC8859684</ArticleId><ArticleId IdType="pubmed">35198136</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M., Geddes J.R., Husain M., Luciano S., Harrison P.J. 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: A retrospective cohort study using electronic health records. Lancet Psychiatry. 2021;8:416&#x2013;427. doi: 10.1016/S2215-0366(21)00084-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(21)00084-5</ArticleId><ArticleId IdType="pmc">PMC8023694</ArticleId><ArticleId IdType="pubmed">33836148</ArticleId></ArticleIdList></Reference><Reference><Citation>Huber R., M&#xe4;ki H., Rosanova M., Casarotto S., Canali P., Casali A.G., Tononi G., Massimini M. Human cortical excitability increases with time awake. Cereb. Cortex. 2013;23:332&#x2013;338. doi: 10.1093/cercor/bhs014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cercor/bhs014</ArticleId><ArticleId IdType="pmc">PMC3539451</ArticleId><ArticleId IdType="pubmed">22314045</ArticleId></ArticleIdList></Reference><Reference><Citation>Lanza G., Cantone M., Lanuzza B., Pennisi M., Bella R., Pennisi G., Ferri R. Distinctive patterns of cortical excitability to transcranial magnetic stimulation in obstructive sleep apnea syndrome, restless legs syndrome, insomnia, and sleep deprivation. Sleep Med. Rev. 2015;19:39&#x2013;50. doi: 10.1016/j.smrv.2014.04.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.smrv.2014.04.001</ArticleId><ArticleId IdType="pubmed">24849846</ArticleId></ArticleIdList></Reference><Reference><Citation>Plante D.T., Jensen J.E., Schoerning L., Winkelman J.W. Reduced &#x3b3;-aminobutyric acid in occipital and anterior cingulate cortices in primary insomnia: A link to major depressive disorder? Neuropsychopharmacology. 2012;37:1548&#x2013;1557. doi: 10.1038/npp.2012.4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/npp.2012.4</ArticleId><ArticleId IdType="pmc">PMC3327859</ArticleId><ArticleId IdType="pubmed">22318195</ArticleId></ArticleIdList></Reference><Reference><Citation>Winkelman J.W., Buxton O.M., Jensen J.E., Benson K.L., O&#x2019;Connor S.P., Wang W., Renshaw P.F. Reduced brain GABA in primary insomnia: Preliminary data from 4T proton magnetic resonance spectroscopy (1H-MRS) Sleep. 2008;31:1499&#x2013;1506. doi: 10.1093/sleep/31.11.1499.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/sleep/31.11.1499</ArticleId><ArticleId IdType="pmc">PMC2579978</ArticleId><ArticleId IdType="pubmed">19014069</ArticleId></ArticleIdList></Reference><Reference><Citation>Roth T. A physiologic basis for the evolution of pharmacotherapy for insomnia. J. Clin. Psychiatry. 2007;68:13.</Citation><ArticleIdList><ArticleId IdType="pubmed">17539704</ArticleId></ArticleIdList></Reference><Reference><Citation>Godfrey K.E., Gardner A.C., Kwon S., Chea W., Muthukumaraswamy S.D. Differences in excitatory and inhibitory neurotransmitter levels between depressed patients and healthy controls: A systematic review and meta-analysis. J. Psychiatr. Res. 2018;105:33&#x2013;44. doi: 10.1016/j.jpsychires.2018.08.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpsychires.2018.08.015</ArticleId><ArticleId IdType="pubmed">30144668</ArticleId></ArticleIdList></Reference><Reference><Citation>Luscher B., Fuchs T. Advances in Pharmacology. Volume 73. Elsevier; Amsterdam, The Netherlands: 2015. GABAergic control of depression-related brain states; pp. 97&#x2013;144.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4784429</ArticleId><ArticleId IdType="pubmed">25637439</ArticleId></ArticleIdList></Reference><Reference><Citation>Foga&#xe7;a M.V., Duman R.S. Cortical GABAergic dysfunction in stress and depression: New insights for therapeutic interventions. Front. Cell. Neurosci. 2019;13:87. doi: 10.3389/fncel.2019.00087.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2019.00087</ArticleId><ArticleId IdType="pmc">PMC6422907</ArticleId><ArticleId IdType="pubmed">30914923</ArticleId></ArticleIdList></Reference><Reference><Citation>Cutler A.J., Mattingly G.W., Maletic V. Understanding the mechanism of action and clinical effects of neuroactive steroids and GABAergic compounds in major depressive disorder. Transl. Psychiatry. 2023;13:228. doi: 10.1038/s41398-023-02514-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41398-023-02514-2</ArticleId><ArticleId IdType="pmc">PMC10293235</ArticleId><ArticleId IdType="pubmed">37365161</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanacora G., Mason G.F., Rothman D.L., Krystal J.H. Increased occipital cortex GABA concentrations in depressed patients after therapy with selective serotonin reuptake inhibitors. Am. J. Psychiatry. 2002;159:663&#x2013;665. doi: 10.1176/appi.ajp.159.4.663.</Citation><ArticleIdList><ArticleId IdType="doi">10.1176/appi.ajp.159.4.663</ArticleId><ArticleId IdType="pubmed">11925309</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanacora G., Mason G.F., Rothman D.L., Hyder F., Ciarcia J.J., Ostroff R.B., Berman R.M., Krystal J.H. Increased cortical GABA concentrations in depressed patients receiving ECT. Am. J. Psychiatry. 2003;160:577&#x2013;579. doi: 10.1176/appi.ajp.160.3.577.</Citation><ArticleIdList><ArticleId IdType="doi">10.1176/appi.ajp.160.3.577</ArticleId><ArticleId IdType="pubmed">12611844</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdallah C.G., Niciu M.J., Fenton L.R., Fasula M.K., Jiang L., Black A., Rothman D.L., Mason G.F., Sanacora G. Decreased occipital cortical glutamate levels in response to successful cognitive-behavioral therapy and pharmacotherapy for major depressive disorder. Psychother. Psychosom. 2014;83:298&#x2013;307. doi: 10.1159/000361078.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000361078</ArticleId><ArticleId IdType="pmc">PMC4164203</ArticleId><ArticleId IdType="pubmed">25116726</ArticleId></ArticleIdList></Reference><Reference><Citation>Caverzasi E., Pichiecchio A., Poloni G.U., Calligaro A., Pasin M., Palesi F., Castellazzi G., Pasquini M., Biondi M., Barale F. Magnetic resonance spectroscopy in the evaluation of treatment efficacy in unipolar major depressive disorder: A review of the literature. Funct. Neurol. 2012;27:13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3812759</ArticleId><ArticleId IdType="pubmed">22687162</ArticleId></ArticleIdList></Reference><Reference><Citation>Nutt D., Wilson S., Paterson L. Sleep disorders as core symptoms of depression. Dialogues Clin. Neurosci. 2022;10:329&#x2013;336. doi: 10.31887/DCNS.2008.10.3/dnutt.</Citation><ArticleIdList><ArticleId IdType="doi">10.31887/DCNS.2008.10.3/dnutt</ArticleId><ArticleId IdType="pmc">PMC3181883</ArticleId><ArticleId IdType="pubmed">18979946</ArticleId></ArticleIdList></Reference><Reference><Citation>Mollayeva T., Thurairajah P., Burton K., Mollayeva S., Shapiro C.M., Colantonio A. The Pittsburgh sleep quality index as a screening tool for sleep dysfunction in clinical and non-clinical samples: A systematic review and meta-analysis. Sleep Med. Rev. 2016;25:52&#x2013;73. doi: 10.1016/j.smrv.2015.01.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.smrv.2015.01.009</ArticleId><ArticleId IdType="pubmed">26163057</ArticleId></ArticleIdList></Reference><Reference><Citation>Berk M., Williams L.J., Jacka F.N., O&#x2019;Neil A., Pasco J.A., Moylan S., Allen N.B., Stuart A.L., Hayley A.C., Byrne M.L. So depression is an inflammatory disease, but where does the inflammation come from? BMC Med. 2013;11:200. doi: 10.1186/1741-7015-11-200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1741-7015-11-200</ArticleId><ArticleId IdType="pmc">PMC3846682</ArticleId><ArticleId IdType="pubmed">24228900</ArticleId></ArticleIdList></Reference><Reference><Citation>Roohi E., Jaafari N., Hashemian F. On inflammatory hypothesis of depression: What is the role of IL-6 in the middle of the chaos? J. Neuroinflammation. 2021;18:45. doi: 10.1186/s12974-021-02100-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-021-02100-7</ArticleId><ArticleId IdType="pmc">PMC7884972</ArticleId><ArticleId IdType="pubmed">33593388</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakhaee H., Zangiabadian M., Bayati R., Rahmanian M., Ghaffari Jolfayi A., Rakhshanderou S. The effect of antidepressants on the severity of COVID-19 in hospitalized patients: A systematic review and meta-analysis. PLoS ONE. 2022;17:e0267423. doi: 10.1371/journal.pone.0267423.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0267423</ArticleId><ArticleId IdType="pmc">PMC9536564</ArticleId><ArticleId IdType="pubmed">36201406</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu Y., Ho C.S., Liu X., Chua A.N., Wang W., McIntyre R.S., Ho R.C. Chronic administration of fluoxetine and pro-inflammatory cytokine change in a rat model of depression. PLoS ONE. 2017;12:e0186700. doi: 10.1371/journal.pone.0186700.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0186700</ArticleId><ArticleId IdType="pmc">PMC5648231</ArticleId><ArticleId IdType="pubmed">29049348</ArticleId></ArticleIdList></Reference><Reference><Citation>Cui C., Shurtleff D., Harris R.A. Neuroimmune mechanisms of alcohol and drug addiction. Int. Rev. Neurobiol. 2014;118:1&#x2013;12. doi: 10.1016/B978-0-12-801284-0.00001-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/B978-0-12-801284-0.00001-4</ArticleId><ArticleId IdType="pmc">PMC4804710</ArticleId><ArticleId IdType="pubmed">25175859</ArticleId></ArticleIdList></Reference><Reference><Citation>Hodes G.E., Kana V., Menard C., Merad M., Russo S.J. Neuroimmune mechanisms of depression. Nat. Neurosci. 2015;18:1386&#x2013;1393. doi: 10.1038/nn.4113.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.4113</ArticleId><ArticleId IdType="pmc">PMC4843114</ArticleId><ArticleId IdType="pubmed">26404713</ArticleId></ArticleIdList></Reference><Reference><Citation>Tzingounis A.V., Wadiche J.I. Glutamate transporters: Confining runaway excitation by shaping synaptic transmission. Nat. Rev. Neurosci. 2007;8:935&#x2013;947. doi: 10.1038/nrn2274.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn2274</ArticleId><ArticleId IdType="pubmed">17987031</ArticleId></ArticleIdList></Reference><Reference><Citation>Wohleb E.S., Franklin T., Iwata M., Duman R.S. Integrating neuroimmune systems in the neurobiology of depression. Nat. Rev. Neurosci. 2016;17:497&#x2013;511. doi: 10.1038/nrn.2016.69.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn.2016.69</ArticleId><ArticleId IdType="pubmed">27277867</ArticleId></ArticleIdList></Reference><Reference><Citation>Versace V., Sebastianelli L., Ferrazzoli D., Romanello R., Ortelli P., Saltuari L., D&#x2019;Acunto A., Porrazzini F., Ajello V., Oliviero A. Intracortical GABAergic dysfunction in patients with fatigue and dysexecutive syndrome after COVID-19. Clin. Neurophysiol. 2021;132:1138&#x2013;1143. doi: 10.1016/j.clinph.2021.03.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinph.2021.03.001</ArticleId><ArticleId IdType="pmc">PMC7954785</ArticleId><ArticleId IdType="pubmed">33774378</ArticleId></ArticleIdList></Reference><Reference><Citation>Furlanis G., Buoite Stella A., Biaduzzini F., Bellavita G., Frezza N.A., Olivo S., Menichelli A., Lunardelli A., Aj&#x10d;evi&#x107; M., Manganotti P. Cognitive deficit in post-acute COVID-19: An opportunity for EEG evaluation? Neurol. Sci. 2023;44:1491&#x2013;1498. doi: 10.1007/s10072-023-06615-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-023-06615-0</ArticleId><ArticleId IdType="pmc">PMC9902820</ArticleId><ArticleId IdType="pubmed">36749529</ArticleId></ArticleIdList></Reference><Reference><Citation>Yesilkaya U.H., Sen M., Balcioglu Y.H. COVID-19-related cognitive dysfunction may be associated with transient disruption in the DLPFC glutamatergic pathway. J. Clin. Neurosci. 2021;87:153&#x2013;155. doi: 10.1016/j.jocn.2021.03.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jocn.2021.03.007</ArticleId><ArticleId IdType="pmc">PMC7955917</ArticleId><ArticleId IdType="pubmed">33863524</ArticleId></ArticleIdList></Reference><Reference><Citation>Rapalino O., Weerasekera A., Moum S.J., Eikermann-Haerter K., Edlow B.L., Fischer D., Torrado-Carvajal A., Loggia M.L., Mukerji S.S., Schaefer P.W., et al. Brain MR Spectroscopic Findings in 3 Consecutive Patients with COVID-19: Preliminary Observations. AJNR Am. J. Neuroradiol. 2021;42:37&#x2013;41. doi: 10.3174/ajnr.A6877.</Citation><ArticleIdList><ArticleId IdType="doi">10.3174/ajnr.A6877</ArticleId><ArticleId IdType="pmc">PMC7814804</ArticleId><ArticleId IdType="pubmed">33122208</ArticleId></ArticleIdList></Reference><Reference><Citation>Newhouse A., Kritzer M.D., Eryilmaz H., Praschan N., Camprodon J.A., Fricchione G., Chemali Z. Neurocircuitry hypothesis and clinical experience in treating neuropsychiatric symptoms of postacute sequelae of severe acute respiratory syndrome coronavirus 2. J. Acad. Consult. Liaison Psychiatry. 2022;63:619&#x2013;627. doi: 10.1016/j.jaclp.2022.08.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaclp.2022.08.007</ArticleId><ArticleId IdType="pmc">PMC9404079</ArticleId><ArticleId IdType="pubmed">36030055</ArticleId></ArticleIdList></Reference><Reference><Citation>Baig A.M. Differential diagnosis and pathogenesis of the neurological signs and symptoms in COVID-19 and long-COVID syndrome. CNS Neurosci. Ther. 2022;28:1905&#x2013;1907. doi: 10.1111/cns.13957.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cns.13957</ArticleId><ArticleId IdType="pmc">PMC9539369</ArticleId><ArticleId IdType="pubmed">36117492</ArticleId></ArticleIdList></Reference><Reference><Citation>Bookstaver P.B., Mohorn P.L., Shah A., Tesh L.D., Quidley A.M., Kothari R., Bland C.M., Weissman S. Management of viral central nervous system infections: A primer for clinicians. J. Cent. Nerv. Syst. Dis. 2017;9:1179573517703342. doi: 10.1177/1179573517703342.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1179573517703342</ArticleId><ArticleId IdType="pmc">PMC5415352</ArticleId><ArticleId IdType="pubmed">28579869</ArticleId></ArticleIdList></Reference><Reference><Citation>Schifitto G., Navia B.A., Yiannoutsos C.T., Marra C.M., Chang L., Ernst T., Jarvik J.G., Miller E.N., Singer E.J., Ellis R.J. Memantine and HIV-associated cognitive impairment: A neuropsychological and proton magnetic resonance spectroscopy study. Aids. 2007;21:1877&#x2013;1886. doi: 10.1097/QAD.0b013e32813384e8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/QAD.0b013e32813384e8</ArticleId><ArticleId IdType="pubmed">17721095</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonul A.S., Kitis O., Ozan E., Akdeniz F., Eker C., Eker O.D., Vahip S. The effect of antidepressant treatment on N-acetyl aspartate levels of medial frontal cortex in drug-free depressed patients. Prog. Neuro-Psychopharmacol. Biol. Psychiatry. 2006;30:120&#x2013;125. doi: 10.1016/j.pnpbp.2005.08.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pnpbp.2005.08.017</ArticleId><ArticleId IdType="pubmed">16236417</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Y., Chen W., Li Y., Wu X., Shi X., Geng D. Effects of antidepressant treatment on N-acetyl aspartate and choline levels in the hippocampus and thalami of post-stroke depression patients: A study using 1H magnetic resonance spectroscopy. Psychiatry Res. Neuroimaging. 2010;182:48&#x2013;52. doi: 10.1016/j.pscychresns.2009.11.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pscychresns.2009.11.009</ArticleId><ArticleId IdType="pubmed">20227856</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel T., Blyth J.C., Griffiths G., Kelly D., Talcott J.B. Moderate relationships between NAA and cognitive ability in healthy adults: Implications for cognitive spectroscopy. Front. Hum. Neurosci. 2014;8:39. doi: 10.3389/fnhum.2014.00039.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnhum.2014.00039</ArticleId><ArticleId IdType="pmc">PMC3924143</ArticleId><ArticleId IdType="pubmed">24592224</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>